231 - 240 of 8825 Results
Title
Year
-
RESTRICTEDTitle: Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained LoopJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 8Start Page: 427End Page: 440Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11910-022-01207-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11910-022-01207-5.pdfCitation Count: 23
-
RESTRICTEDTitle: Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and CannabisJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1434End Page: 1455Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00900-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00900-y.pdfCitation Count: 49
-
RESTRICTEDTitle: Management of Tardive Syndrome: Medications and Surgical TreatmentsJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1694End Page: 1712Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00898-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00898-3.pdfCitation Count: 15
- Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons Learned2020RESTRICTEDTitle: Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons LearnedJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1393End Page: 1405Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00964-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00964-w.pdfCitation Count: 20
-
RESTRICTEDTitle: Symptomatic Care in Multiple System Atrophy: State of the ArtJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 22Issue #: 3Start Page: 433End Page: 446Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-022-01411-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-022-01411-6.pdfCitation Count: 7
-
RESTRICTEDTitle: Digital Technology in Movement Disorders: Updates, Applications, and ChallengesJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 21Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-021-01101-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11910-021-01101-6.pdfCitation Count: 30
-
RESTRICTEDTitle: Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson’s DiseaseJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 34Issue #: 6Start Page: 559End Page: 577Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-020-00727-3Citation Count: 6
-
RESTRICTEDTitle: 24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical RecommendationsJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 2Start Page: 137End Page: 149Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-020-00782-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-020-00782-w.pdfCitation Count: 17
-
RESTRICTEDTitle: Targeting β-Arrestins in the Treatment of Psychiatric and Neurological DisordersJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 3Start Page: 253End Page: 264Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-021-00796-yCitation Count: 8
-
RESTRICTEDTitle: Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysisJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 12Start Page: 1269End Page: 1283Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-022-00963-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-022-00963-9.pdfCitation Count: 14